BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26095858)

  • 1. Structure and function of Gab2 and its role in cancer (Review).
    Ding CB; Yu WN; Feng JH; Luo JM
    Mol Med Rep; 2015 Sep; 12(3):4007-4014. PubMed ID: 26095858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
    Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
    Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gab docking proteins in cardiovascular disease, cancer, and inflammation.
    Nakaoka Y; Komuro I
    Int J Inflam; 2013; 2013():141068. PubMed ID: 23431498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase.
    Liu Y; Jenkins B; Shin JL; Rohrschneider LR
    Mol Cell Biol; 2001 May; 21(9):3047-56. PubMed ID: 11287610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.
    Zhang X; Lavoie G; Méant A; Aubert L; Cargnello M; Haman A; Hoang T; Roux PP
    Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28096188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAB2--a scaffolding protein in cancer.
    Adams SJ; Aydin IT; Celebi JT
    Mol Cancer Res; 2012 Oct; 10(10):1265-70. PubMed ID: 22871571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease.
    Pan XL; Ren RJ; Wang G; Tang HD; Chen SD
    Neurosci Bull; 2010 Jun; 26(3):241-6. PubMed ID: 20502503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis.
    Gu H; Botelho RJ; Yu M; Grinstein S; Neel BG
    J Cell Biol; 2003 Jun; 161(6):1151-61. PubMed ID: 12821647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.
    Wöhrle FU; Halbach S; Aumann K; Schwemmers S; Braun S; Auberger P; Schramek D; Penninger JM; Laßmann S; Werner M; Waller CF; Pahl HL; Zeiser R; Daly RJ; Brummer T
    Leukemia; 2013 Jan; 27(1):118-29. PubMed ID: 22858987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptor.
    Frigault MM; Naujokas MA; Park M
    J Cell Physiol; 2008 Mar; 214(3):694-705. PubMed ID: 17894413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.
    Meng S; Chen Z; Munoz-Antonia T; Wu J
    Biochem J; 2005 Oct; 391(Pt 1):143-51. PubMed ID: 15952937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.
    Zhang X; Lavoie G; Fort L; Huttlin EL; Tcherkezian J; Galan JA; Gu H; Gygi SP; Carreno S; Roux PP
    Mol Cell Biol; 2013 Apr; 33(8):1657-70. PubMed ID: 23401857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gab2 tyrosine phosphorylation by a pleckstrin homology domain-independent mechanism: role in epidermal growth factor-induced mitogenesis.
    Kong M; Mounier C; Balbis A; Baquiran G; Posner BI
    Mol Endocrinol; 2003 May; 17(5):935-44. PubMed ID: 12595575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis.
    Wang W; Xu S; Yin M; Jin ZG
    Int J Cardiol; 2015 Feb; 181():180-4. PubMed ID: 25528308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.
    Osinalde N; Sánchez-Quiles V; Blagoev B; Kratchmarova I
    Sci Rep; 2016 Mar; 6():23530. PubMed ID: 27025927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure and function of the adapter protein Gab and its role in the development of tumor, inflammation and cardiovascular diseases].
    Li AY; Guo XX; Liu Y; Yang Y; Xu TR; An S
    Sheng Li Xue Bao; 2016 Feb; 68(1):57-64. PubMed ID: 26915323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
    Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
    Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.
    Futami M; Zhu QS; Whichard ZL; Xia L; Ke Y; Neel BG; Feng GS; Corey SJ
    Blood; 2011 Jul; 118(4):1077-86. PubMed ID: 21636860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2.
    Breitkopf SB; Yang X; Begley MJ; Kulkarni M; Chiu YH; Turke AB; Lauriol J; Yuan M; Qi J; Engelman JA; Hong P; Kontaridis MI; Cantley LC; Perrimon N; Asara JM
    Sci Rep; 2016 Feb; 6():20471. PubMed ID: 26839216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.